IL-17, IL-6 and IFN-γ in systemic sclerosis patients

1. BREMBILLA NC, CHIZZOLINI C. T cell abnormalities in systemic sclerosis with a focus on Th17 cells. Eur Cytokine Netw. 2012; 23(4):128-39.10.1684/ecn.2013.032523360781Search in Google Scholar

2. ZHU J, PAUL WE. CD4 T cells: fates, functions, and faults. Blood. 2008; 112(5):1557-69.10.1182/blood-2008-05-078154251887218725574Search in Google Scholar

3. PAVLOVIC V, DIMIC A, MILENKOVIC S, KRTINIC D. Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis. J Res Med Sci. 2014; 19(1):18-22.Search in Google Scholar

4. BĂLĂNESCU P, BĂLĂNESCU E, TĂNĂSESCU C, NICOLAU A, TĂNĂSESCU R, GRANCEA C, VAGU C, RUŢĂ S, BLEOŢU C. T helper 17 cell population in lupus erythematosus. Rom J Intern Med. 2010; 48(3):255-9.Search in Google Scholar

5. TANASESCU C, BALANESCU E, BALANESCU P, OLTEANU R, BADEA C, GRANCEA C, VAGU C, BLEOTU C, ARDELEANU C, GEORGESCU A. IL-17 in cutaneous lupus erythematosus. Eur J Intern Med. 2010; 21(3):202-7.10.1016/j.ejim.2010.03.00420493423Search in Google Scholar

6. CHIZZOLINI C, PAREL Y, SCHEJA A, DAYER JM. Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts. Arthritis Res Ther. 2006; 8(1):R10.10.1186/ar1860152655216356198Search in Google Scholar

7. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.10.1002/art.17802305107378088Search in Google Scholar

8. GALIE N, HOEPER MM, HUMBERT M, TORBICKI A, VACHIERY JL, BARBERA JA, BEGHETTISearch in Google Scholar

9. M, CORRIS P, GAINE S, GIBBS JS, GOMEZ-SANCHEZ MA, JONDEAU G, KLEPETKO W, OPITZ C, PEACOCK A, RUBIN L, ZELLWEGER M, SIMONNEAU G, ESC Committee for Practice. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-2537.10.1093/eurheartj/ehp29719713419Search in Google Scholar

10. CLEMENTS P , LACHENBRUCH P, SEIBOLD J, WHITE B, WEINER S, MARTIN R, WEINSTEIN A, WEISMAN M, MAYES M, COLLIER D. Inter- and intraobserver variability of the total thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22:1281-5.Search in Google Scholar

11. AMANZI L, BRASCHI F, FIORI G, GALLUCCIO F, MINIATI I, GUIDUCCI S, CONFORTI ML, KALOUDI O, NACCI F, SACU O, CANDELIERI A, PIGNONE A, RASERO L, CONFORTI D,MATUCCI-CERINIC M. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatolgy (Oxford) 2010; 49:1374-82.10.1093/rheumatology/keq09720400463Search in Google Scholar

12. VALENTINI G, D’ANGELO S, DELLA ROSSA A, BENCIVELLI W, BOMBARDIERI S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis. 2003; 62(9):904-5.10.1136/ard.62.9.904175465912922969Search in Google Scholar

13. OLEWICZ-GAWLIK A, DANCZAK-PAZDROWSKA A, KUZNAR-KAMINSKA B, GORNOWICZ-POROWSKA J, KATULSKA K, TRZYBULSKA D, BATURA-GABRYEL H, SILNY W, POPLAWSKI D, HRYCAJ P. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis. Int J Rheum Dis. 2014; 17(6):664-70.10.1111/1756-185X.1229024467649Search in Google Scholar

14. MURATA M, FUJIMOTO M, MATSUSHITA T, HAMAGUCHI Y, HASEGAWA M, TAKEHARA K, KOMURA K, SATO S. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci. 2008; 50(3):240-2.10.1016/j.jdermsci.2008.01.00118329249Search in Google Scholar

15. ZHOU Y, HOU W, XU K, HAN D, JIANG C, MOU K, LI Y, MENG L, LU S. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis. Hum Immunol. 2014 Dec 11. pii: S0198-8859(14)00508-4.Search in Google Scholar

16. GOURH P, ARNETT FC, ASSASSI S, TAN FK, HUANG M, DIEKMAN L, MAYES MD, REVEILLE JD, AGARWAL SK. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther. 2009; 11(5):R147.10.1186/ar2821278725919799786Search in Google Scholar

17. RADSTAKE TR, VAN BON L, BROEN J, HUSSIANI A, HESSELSTRAND R, WUTTGE DM, DENG Y, SIMMS R, LUBBERTS E, LAFYATIS R. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One. 2009 Jun 17; 4(6):e5903.10.1371/journal.pone.0005903269199119536281Search in Google Scholar